Roche's $8.3 Billion Deal For InterMune

Peter George Psaras

Web Designer, Author, Portfolio Manager, Quantitative, Technical & Qualitative Analyst • Aug 25, 2014 at 10:43 AM EDT

Drug giant Roche is buying biotech firm InterMune for $8.3 billion. CNBC's Jim Cramer discusses the lifesaving drug behind the wave of M&A deals.

Drug giant Roche is buying biotech firm InterMune for $8.3 billion. CNBC's Jim Cramer discusses the lifesaving drug behind the wave of M&A deals.

None.

STOCKS IN THIS ARTICLE

RHHBY ITMN PFE AZN

Comments

Back to all articles